Timothy W. Trost's most recent trade in Werewolf Therapeutics Inc was a trade of 150,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Werewolf Therapeutics Inc | Timothy W. Trost | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
Werewolf Therapeutics Inc | Timothy W. Trost | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 60,358 | 60,358 | - | - | Stock Option (right to buy) | |
Werewolf Therapeutics Inc | Timothy Trost W. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
Werewolf Therapeutics Inc | Timothy W. Trost | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 102,800 | 102,800 | - | - | Stock Option (right to buy) | |
Werewolf Therapeutics Inc | Timothy W. Trost | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 65,960 | 65,960 | - | - | Stock Option (right to buy) | |
Werewolf Therapeutics Inc | Timothy W. Trost | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 247,812 | 247,812 | - | - | Stock Option (right to buy) | |
Werewolf Therapeutics Inc | Timothy W. Trost | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 54,756 | 54,756 | - | - | Stock Option (right to buy) |